Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Chronic, intermittent convection-enhanced delivery devices

Lewis, Owen, Woolley, Max, Johnson, David, Rosser, Anne Elizabeth ORCID:, Barua, Neil U., Bienemann, Alison S., Gill, Steven S. and Evans, Samuel Lewin ORCID: 2016. Chronic, intermittent convection-enhanced delivery devices. Journal of Neuroscience Methods 259 , pp. 47-56. 10.1016/j.jneumeth.2015.11.008

[thumbnail of Lewis et al 2015.pdf]
PDF - Published Version
Available under License Creative Commons Attribution No Derivatives.

Download (1MB) | Preview


Background Intraparenchymal convection-enhanced delivery (CED) of therapeutics directly into the brain has long been endorsed as a medium through which meaningful concentrations of drug can be administered to patients, bypassing the blood brain barrier. The translation of the technology to clinic has been hindered by poor distribution not previously observed in smaller pre-clinical models. In part this was due to the larger volumes of target structures found in humans but principally the poor outcome was linked to reflux (backflow) of infusate proximally along the catheter track. Over the past 10 years, improvements have been made to the technology in the field which has led to a small number of commercially available devices containing reflux inhibiting features. New method While these devices are currently suitable for acute or short term use, several indications would benefit from longer term repeated, intermittent administration of therapeutics (Parkinson's, Alzheimer's, Amyotrophic lateral sclerosis, Brain tumours such as Glioblastoma Multiforme (GBM) and Diffuse intrinsic Pontine Glioma (DIPG), etc.). Results Despite the need for a chronically accessible platform for such indications, limited experience exists in this part of the field. Comparison with existing method(s) At the time of writing no commercially available clinical platform, indicated for chronic, intermittent or continuous delivery to the brain exists. Conclusions Here we review the improvements that have been made to CED devices over recent years and current state of the art for chronic infusion systems.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Neuroscience and Mental Health Research Institute (NMHRI)
Subjects: T Technology > TA Engineering (General). Civil engineering (General)
Uncontrolled Keywords: Convection-enhanced delivery (CED); Optimisation; Chronic; Intermittent; Catheter
Publisher: Elsevier
ISSN: 0165-0270
Date of First Compliant Deposit: 30 March 2016
Date of Acceptance: 6 November 2015
Last Modified: 17 Jan 2024 07:22

Citation Data

Cited 57 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics